277 related articles for article (PubMed ID: 35370409)
1. Ceftazidime/Avibactam and Other Commonly Used Antibiotics Activity Against Enterobacterales and
Zalas-Więcek P; Prażyńska M; Pojnar Ł; Pałka A; Żabicka D; Orczykowska-Kotyna M; Polak A; Możejko-Pastewka B; Głowacka EA; Pieniążek I; Pawlik M; Grys M; Bogiel M
Infect Drug Resist; 2022; 15():1289-1304. PubMed ID: 35370409
[TBL] [Abstract][Full Text] [Related]
2. In vitro antimicrobial susceptibility of clinical respiratory isolates to ceftazidime-avibactam and comparators (2016-2018).
Piérard D; Stone GG
BMC Infect Dis; 2021 Jun; 21(1):600. PubMed ID: 34162341
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of ceftazidime/avibactam against Gram-negative strains in Colombia 2014-2018.
Lemos-Luengas EV; Rentería-Valoyes S; Cárdenas-Isaza P; Ramos-Castaneda JA
J Glob Antimicrob Resist; 2022 Jun; 29():141-146. PubMed ID: 35257971
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of ceftazidime-avibactam and comparators against Gram-negative bacterial isolates collected in the Asia-Pacific region as part of the INFORM program (2015-2017).
Ko WC; Stone GG
Ann Clin Microbiol Antimicrob; 2020 Apr; 19(1):14. PubMed ID: 32238155
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of ceftazidime-avibactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa collected in Malaysia: Results from the ATLAS Programme, 2013 to 2019.
Tuan Soh TS; Salvinder S; Chen VSY
Med J Malaysia; 2022 Mar; 77(2):174-184. PubMed ID: 35338624
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of ceftazidime-avibactam against Enterobacterales and Pseudomonas aeruginosa isolates collected in Latin America as part of the ATLAS global surveillance program, 2017-2019.
Karlowsky JA; Kazmierczak KM; Valente MLNF; Luengas EL; Baudrit M; Quintana A; Irani P; Stone GG; Sahm DF
Braz J Infect Dis; 2021; 25(6):101647. PubMed ID: 34774471
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of ceftazidime-avibactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa from sub-Saharan Africa: ATLAS Global Surveillance Program 2017-2021.
Wise MG; Karlowsky JA; Hackel MA; Harti MA; Ntshole BME; Njagua EN; Oladele R; Samuel C; Khan S; Wadula J; Lowman W; Lembede BW; Sahm DF
J Glob Antimicrob Resist; 2023 Dec; 35():93-100. PubMed ID: 37709139
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of ceftazidime-avibactam against Gram-negative strains in Chile 2015-2021.
Torres-Castillo LC; Fandiño C; Ramos MP; Ramos-Castaneda JA; Rioseco ML; Juliet C
J Glob Antimicrob Resist; 2023 Dec; 35():143-148. PubMed ID: 37714380
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of ceftazidime-avibactam against Gram-negative isolates collected in 18 European countries, 2015-2017.
Stone GG; Seifert H; Nord CE
Int J Antimicrob Agents; 2020 Sep; 56(3):106045. PubMed ID: 32522673
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial activity of ceftazidime-avibactam and comparators against Pseudomonas aeruginosa and Enterobacterales collected in Croatia, Czech Republic, Hungary, Poland, Latvia and Lithuania: ATLAS Surveillance Program, 2019.
Adámková V; Mareković I; Szabó J; Pojnar L; Billová S; Horvat Herceg S; Kuraieva A; Możejko-Pastewka B
Eur J Clin Microbiol Infect Dis; 2022 Jun; 41(6):989-996. PubMed ID: 35596097
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and in vitro activity of ceftazidime-avibactam and comparator agents against multidrug-resistant isolates of Enterobacterales and Pseudomonas aeruginosa collected in Latin America as part of the ATLAS surveillance program in 2015‒2020.
Wise MG; Karlowsky JA; Lemos-Luengas EV; Valdez RR; Sahm DF
Braz J Infect Dis; 2023; 27(3):102759. PubMed ID: 36977498
[TBL] [Abstract][Full Text] [Related]
12.
Stone G; Wise M; Utt E
Microbiol Spectr; 2024 Mar; 12(3):e0147323. PubMed ID: 38329363
[TBL] [Abstract][Full Text] [Related]
13. Performance of Ceftazidime-Avibactam 30/20-μg and 10/4-μg Disks for Susceptibility Testing of
Han R; Shen S; Yin D; Ding L; Shi Q; Yang Y; Guo Y; Wu S; Zhi P; Zhu D; Hu F
Microbiol Spectr; 2023 Feb; 11(2):e0272022. PubMed ID: 36744897
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility testing of clinical isolates of Gram-negative bacilli collected in Morocco by the ATLAS Global Surveillance Program from 2018 to 2020.
Karlowsky JA; Bouchillon SK; Benaouda A; Soraa N; Zerouali K; Mohamed N; Alami T; Sahm DF
J Glob Antimicrob Resist; 2022 Sep; 30():23-30. PubMed ID: 35447385
[TBL] [Abstract][Full Text] [Related]
15. Time-Kill Evaluation of Antibiotic Combinations Containing Ceftazidime-Avibactam against Extensively Drug-Resistant Pseudomonas aeruginosa and Their Potential Role against Ceftazidime-Avibactam-Resistant Isolates.
Montero MM; Domene Ochoa S; López-Causapé C; Luque S; Sorlí L; Campillo N; López Montesinos I; Padilla E; Prim N; Angulo-Brunet A; Grau S; Oliver A; Horcajada JP
Microbiol Spectr; 2021 Sep; 9(1):e0058521. PubMed ID: 34319141
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of ceftazidime-avibactam and comparators against Enterobacterales and Pseudomonas aeruginosa isolates from Central Europe and Israel, 2014-2017 and 2018.
Kristóf K; Adámková V; Adler A; Gospodarek-Komkowska E; Rafila A; Billová S; Możejko-Pastewka B; Kiss F
Diagn Microbiol Infect Dis; 2021 Sep; 101(1):115420. PubMed ID: 34091111
[TBL] [Abstract][Full Text] [Related]
17.
Karlowsky JA; Kazmierczak KM; Bouchillon SK; de Jonge BLM; Stone GG; Sahm DF
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670424
[TBL] [Abstract][Full Text] [Related]
18.
Karlowsky JA; Kazmierczak KM; Bouchillon SK; de Jonge BLM; Stone GG; Sahm DF
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760124
[TBL] [Abstract][Full Text] [Related]
19.
Yang Y; Guo Y; Yin D; Zheng Y; Wu S; Zhu D; Hu F
Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33139291
[TBL] [Abstract][Full Text] [Related]
20.
Karlowsky JA; Bouchillon SK; El Mahdy Kotb R; Mohamed N; Stone GG; Sahm DF
JAC Antimicrob Resist; 2021 Jun; 3(2):dlab067. PubMed ID: 34223129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
